New endoscopic technique could simplify breast reconstruction after mastectomy

NCT ID NCT07602868

Not yet recruiting Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Aug 05, 2026 · Updated 3 times

Summary

This study will compare a newer, less invasive endoscopic breast reconstruction method (direct-to-implant) with traditional flap surgery (using tissue from the abdomen) in 588 women who had a mastectomy at least one year ago. The goal is to see if the endoscopic approach leads to fewer complications, better cosmetic results, and higher quality of life. The study is not yet recruiting and will follow participants over time to assess outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: endoscopic direct-to-implant breast reconstruction procedure
What this could lead to: If successful, this could offer a less invasive, single-surgery option for breast reconstruction after mastectomy, reducing recovery time and scarring compared to flap surgery.
What could go wrong: This is an early-stage study (prospective cohort) with no random assignment, so results may be biased. The new technique may have higher complication rates or lower patient satisfaction than expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST RECONSTRUCTION AFTER MASTECTOMY

More trials for these conditions

Other studies related to the condition(s) this trial covers.